Investigation Overview
An investigation on behalf of current investors in IDM Pharma Inc. (NASDAQ: IDMI), who purchased their shares before Monday, May 18, 2009, over possible breach of fiduciary duty by the board of directors of IDM Pharma Inc. announced. IDM Pharma announced that Japans Takeda Pharmaceutical Companys subsidiary, Takeda America Holdings, Inc., plans to acquire IDM Pharma for US$2.64 per s...
You must register (for free) or login to view the entire investigation.